Clinical Approach to Nipple Discharge
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of nipple discharge
Nipple discharge is the third most common breast complaint after breast pain and palpable masses, accounting for approximately 5-10% of all breast clinic referrals. While nipple discharge causes significant patient anxiety due to fear of malignancy, the vast majority of cases (approximately 90-95%) are due to benign conditions. However, nipple discharge is the presenting symptom in 5-12% of breast cancers, making systematic evaluation essential. Understanding the characteristics that distinguish physiologic from pathologic discharge is the cornerstone of clinical assessment.
Definition
Nipple discharge is any fluid emanating from the nipple outside the context of lactation. It may originate from the lactiferous ducts (true nipple discharge) or from lesions on the nipple surface (pseudo-discharge). True nipple discharge can be physiologic (normal variant) or pathologic (requiring investigation), with the distinction based on clinical characteristics including spontaneity, laterality, color, and number of ducts involved.
Classification: Physiologic vs Pathologic Discharge
| Feature | Physiologic Discharge | Pathologic Discharge |
|---|---|---|
| Spontaneity | Expressed only (requires manipulation) | Spontaneous (stains bra/clothing) |
| Laterality | Bilateral | Unilateral |
| Duct involvement | Multiple ducts | Single duct (uniductal) |
| Color | Milky, green, yellow, gray | Bloody, serous (clear/watery) |
| Associated mass | Absent | May be present |
| Clinical action | Reassurance, address underlying cause if galactorrhea | Requires imaging and possible surgical evaluation |
Classification by Color and Character
| Color/Character | Description | Common Causes | Clinical Significance |
|---|---|---|---|
| Milky (white) | Resembles breast milk, bilateral, multiductal | Galactorrhea (hyperprolactinemia, medications, hypothyroidism) | Endocrine workup indicated; low malignancy risk |
| Clear/Serous | Watery, transparent, often spontaneous | Intraductal papilloma, duct ectasia, early carcinoma | Requires investigation; second highest malignancy association |
| Bloody/Serosanguinous | Red or pink, may be guaiac-positive | Intraductal papilloma (most common), carcinoma, duct ectasia | Highest concern for malignancy; always investigate |
| Green/Yellow | Thick, sticky, often bilateral | Fibrocystic changes, duct ectasia | Usually benign; low malignancy risk |
| Multicolored/Sticky | Variable colors (green, brown, gray), bilateral | Mammary duct ectasia | Benign; reassurance appropriate |
| Purulent | Thick, yellow-green, malodorous | Breast abscess, mastitis, infected cyst | Infectious etiology; requires treatment |
Classification by Pattern and Timing
By Spontaneity
Spontaneous: Occurs without nipple manipulation; stains undergarments. More concerning for pathology including malignancy.
Expressed: Occurs only with nipple manipulation or breast compression. Usually physiologic and requires less aggressive workup.
By Duct Involvement
Uniductal (single duct): Discharge from one ductal orifice. Suggests localized pathology such as papilloma or carcinoma. Higher concern.
Multiductal (multiple ducts): Discharge from several ducts. Suggests systemic or diffuse process. Usually benign.
| Pattern | Description | Suggests |
|---|---|---|
| Cyclical | Discharge varies with menstrual cycle | Fibrocystic changes, hormonal influence |
| Persistent/Continuous | Present throughout the cycle without variation | Structural lesion (papilloma, carcinoma) |
| Intermittent | Comes and goes without clear pattern | Duct ectasia, fibrocystic changes |
| New onset in postmenopausal woman | Any discharge in postmenopausal patient | Higher index of suspicion for malignancy |
The “Pathologic Triad” — Features That Demand Investigation:
- Spontaneous — occurs without manipulation
- Unilateral and uniductal — from one breast and one duct
- Bloody or clear/serous — concerning colors
When all three features are present, the risk of underlying malignancy is approximately 10-15%. Any one feature warrants careful evaluation.
Age-Related Considerations
| Age Group | Common Causes | Malignancy Risk | Key Considerations |
|---|---|---|---|
| Premenopausal (under 50) | Intraductal papilloma, fibrocystic changes, galactorrhea | Lower (approximately 5%) | Hormonal influences common; still evaluate pathologic discharge |
| Perimenopausal (45-55) | Duct ectasia, papilloma, early carcinoma | Moderate (approximately 10%) | Transition period; maintain vigilance |
| Postmenopausal (over 50) | Duct ectasia, carcinoma, papilloma | Higher (approximately 15-20%) | All spontaneous discharge requires investigation |
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of nipple discharge
The breast is composed of 15-20 lobes, each drained by a lactiferous duct that converges at the nipple. Understanding the anatomy of the ductal system and the physiologic regulation of breast secretions is essential for interpreting the significance of nipple discharge. Different pathologic processes affect distinct anatomical locations and produce characteristic types of discharge based on their underlying mechanisms.
Functional Breast Anatomy
| Structure | Location | Function | Clinical Relevance |
|---|---|---|---|
| Terminal duct-lobular unit (TDLU) | Peripheral breast tissue | Site of milk production; functional unit of the breast | Origin of most breast pathology including carcinomas |
| Lactiferous ducts | Converge toward nipple (15-20 per breast) | Transport secretions from lobules to nipple | Papillomas arise here; uniductal discharge localizes to one duct |
| Lactiferous sinuses | Subareolar region (dilated portion of ducts) | Reservoir for milk during lactation | Duct ectasia affects this region; subareolar masses common |
| Nipple | Central projection of breast | Exit point for 15-20 ductal orifices | Discharge character and duct location aid diagnosis |
Hormonal Regulation of Breast Secretion
Prolactin
Source: Anterior pituitary lactotroph cells
Function: Primary hormone stimulating milk production
Regulation: Tonically inhibited by dopamine from hypothalamus
Clinical relevance: Elevated prolactin causes galactorrhea; dopamine antagonists remove inhibition
Estrogen and Progesterone
Source: Ovaries (premenopausal), adipose tissue, adrenal glands
Function: Ductal and lobular development; prepare breast for lactation
Regulation: Cyclic variation with menstrual cycle
Clinical relevance: Explains cyclical breast changes and discharge variation
Oxytocin
Source: Posterior pituitary
Function: Milk ejection (let-down reflex)
Regulation: Released in response to nipple stimulation
Clinical relevance: Nipple manipulation can induce discharge in susceptible individuals
How Conditions Cause Nipple Discharge
| Condition | Mechanism | Discharge Characteristics | Clinical Implication |
|---|---|---|---|
| Intraductal papilloma | Benign proliferation of ductal epithelium on fibrovascular stalk; fragile vessels prone to bleeding; located in major subareolar ducts | Bloody or serous; spontaneous; unilateral; uniductal | Most common cause of pathologic bloody discharge; surgical excision often needed |
| Mammary duct ectasia | Dilation and shortening of subareolar ducts with periductal inflammation; lipid-rich debris accumulates; ducts may rupture causing inflammation | Multicolored (green, brown, gray); thick and sticky; bilateral; multiductal | Common in perimenopausal women; benign; may cause nipple retraction |
| Galactorrhea (hyperprolactinemia) | Elevated prolactin stimulates alveolar epithelium to produce milk; causes include pituitary adenoma, medications (dopamine antagonists), hypothyroidism, chest wall stimulation | Milky (white); bilateral; multiductal; expressed | Requires endocrine workup; treat underlying cause |
| Fibrocystic changes | Exaggerated response to cyclic hormonal stimulation; cyst formation with apocrine metaplasia; increased ductal secretions | Yellow or green; often cyclical; bilateral; multiductal | Very common; benign; may resolve with menopause |
| Breast carcinoma (ductal carcinoma in situ or invasive) | Malignant cells obstruct and erode ducts; tumor neovascularization creates fragile vessels; cellular necrosis produces debris | Bloody or clear; spontaneous; unilateral; uniductal; may have associated mass | Accounts for 5-15% of pathologic discharge; always exclude with appropriate workup |
| Breast abscess/Mastitis | Bacterial infection (often Staphylococcus aureus) causes purulent inflammation; may complicate duct ectasia or periareolar fistula | Purulent; malodorous; unilateral; associated with pain, erythema, fever | Requires antibiotics; may need drainage; rule out inflammatory breast cancer |
| Paget disease of the nipple | Intraepithelial spread of underlying ductal carcinoma to nipple epidermis; malignant cells migrate through ducts to nipple surface | Serous or bloody; associated with nipple skin changes (eczematous, ulcerated) | Always associated with underlying carcinoma (in situ or invasive); requires full workup |
Mechanisms of Hyperprolactinemia (Causing Galactorrhea)
| Category | Examples | Mechanism |
|---|---|---|
| Pituitary causes | Prolactinoma, non-functioning pituitary adenoma, empty sella syndrome | Direct prolactin secretion or stalk compression reducing dopamine delivery |
| Hypothalamic causes | Craniopharyngioma, sarcoidosis, head trauma, stalk transection | Disruption of dopamine inhibition pathway |
| Medications | Antipsychotics (risperidone, haloperidol), metoclopramide, domperidone, SSRIs, opioids, verapamil | Dopamine receptor blockade or dopamine depletion |
| Primary hypothyroidism | Hashimoto thyroiditis, iodine deficiency, post-thyroidectomy | Elevated TRH stimulates both TSH and prolactin release |
| Chest wall stimulation | Herpes zoster, thoracotomy scars, nipple piercing, tight clothing | Afferent neural stimulation mimics suckling reflex |
| Other | Chronic renal failure, liver cirrhosis, polycystic ovary syndrome | Reduced prolactin clearance or altered dopamine metabolism |
Often Overlooked Mechanism: The “Stalk Effect”
Any mass or process compressing the pituitary stalk can cause hyperprolactinemia, even if the lesion does not produce prolactin. This occurs because compression disrupts the delivery of dopamine (prolactin-inhibiting hormone) from the hypothalamus to the pituitary. Therefore, a large non-functioning pituitary adenoma can cause galactorrhea, but prolactin levels are typically only mildly to moderately elevated (usually less than 100 ng/mL). In contrast, prolactinomas produce prolactin directly and cause very high levels (often greater than 200 ng/mL for macroadenomas). This distinction helps differentiate the underlying cause.
Why Bloody Discharge Requires Investigation
Pathophysiologic Basis for Concern:
Bloody nipple discharge indicates disruption of the ductal epithelium with exposure of blood vessels. This occurs in three main scenarios:
- Intraductal papilloma: Fragile papillary projections with delicate fibrovascular cores bleed easily with minor trauma
- Ductal carcinoma: Malignant cells erode through ductal walls; tumor neovascularization creates abnormal, friable vessels
- Duct ectasia with inflammation: Periductal inflammation can cause vascular congestion and occasional bleeding
While intraductal papilloma causes approximately 50-60% of bloody discharge cases, carcinoma accounts for 10-15%, making thorough investigation mandatory.
Pseudo-Discharge: An Important Distinction
Not All Nipple Fluid is True Discharge
Pseudo-discharge originates from the nipple surface rather than the lactiferous ducts. Causes include nipple eczema, Paget disease of the nipple, and traumatic erosions. The key distinguishing feature is that pseudo-discharge comes from the nipple surface (not from ductal orifices) and is often associated with visible skin changes. Paget disease is particularly important to recognize as it indicates underlying malignancy in nearly all cases.
3. History Taking
A comprehensive approach to eliciting the nipple discharge history
Red Flags — Require Urgent Evaluation
- Bloody or serosanguinous discharge — papilloma or carcinoma
- Spontaneous, unilateral, uniductal discharge — localized pathology
- Associated palpable breast mass — possible malignancy
- Nipple skin changes (eczema, ulceration) — Paget disease
- New nipple retraction or inversion — underlying tumor
- Postmenopausal onset — higher malignancy risk
- Personal history of breast cancer — recurrence concern
- Visual field defects or headaches with galactorrhea — pituitary tumor
Systematic History: The “NIPPLE” Approach
Use the mnemonic “NIPPLE” to ensure comprehensive history taking:
- N — Nature and Number: What color is the discharge? Is it from one duct or multiple ducts? One breast or both?
- I — Initiation: Is it spontaneous or only when you squeeze the nipple? Does it stain your bra or clothing?
- P — Pattern and Persistence: How long has it been present? Is it constant or intermittent? Does it vary with your menstrual cycle?
- P — Precipitants and Pills: What triggers it? Any new medications? Recent chest wall trauma or surgery?
- L — Lumps and Lactation: Have you noticed any breast lumps? Could you be pregnant? Are you breastfeeding or recently stopped?
- E — Endocrine and Extra symptoms: Any menstrual irregularities? Headaches or vision changes? Hot flashes? Fatigue or weight changes?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Intraductal papilloma | Bloody or clear discharge; unilateral; uniductal; spontaneous; no mass | “Does the discharge come from just one spot on your nipple, or from several openings?” |
| Breast carcinoma | Bloody or clear discharge; associated mass; skin changes; nipple retraction | “Have you noticed any lumps, skin dimpling, or changes in the shape of your nipple?” |
| Mammary duct ectasia | Multicolored sticky discharge; bilateral; multiductal; perimenopausal | “Is the discharge thick and sticky? Does it come in different colors like green, brown, or gray?” |
| Galactorrhea (hyperprolactinemia) | Milky discharge; bilateral; multiductal; menstrual irregularity; headaches | “Is the discharge milky white like breast milk? Have your periods changed or stopped?” |
| Prolactinoma | Galactorrhea plus headaches, visual disturbance, amenorrhea | “Have you had any headaches, especially in the front of your head? Any changes in your side vision?” |
| Fibrocystic changes | Green or yellow discharge; cyclical breast pain; bilateral; premenopausal | “Does your breast tenderness or the discharge get worse before your period?” |
| Paget disease of the nipple | Nipple eczema, scaling, ulceration; unilateral; may have underlying mass | “Have you noticed any rash, scaling, or sores on your nipple that won’t heal?” |
| Breast abscess or mastitis | Purulent discharge; pain; redness; fever; recent lactation | “Is your breast red, hot, or swollen? Do you have fever or feel unwell?” |
| Drug-induced galactorrhea | Milky discharge after starting new medication; bilateral | “Have you started any new medications in the past few months, including psychiatric medications, anti-nausea drugs, or blood pressure medications?” |
| Hypothyroidism | Galactorrhea with fatigue, weight gain, cold intolerance, constipation | “Have you noticed weight gain, feeling cold, constipation, or unusual tiredness?” |
Essential Questions About the Discharge Itself
Color and Character
- “What color is the discharge?” — milky, clear, yellow, green, brown, bloody
- “Is it watery, thick, or sticky?”
- “Does the color ever change or is it always the same?”
- “Have you noticed any blood or pink staining?”
Quantity and Behavior
- “How much discharge is there? A drop, or enough to soak through?”
- “Does it come out on its own, or only when you squeeze?”
- “Does it stain your bra or nightclothes?”
- “Is it from one breast or both? One spot or multiple?”
Medication and Social History
Medications That Cause Galactorrhea
- Antipsychotics — risperidone, haloperidol, olanzapine (dopamine antagonism)
- Antiemetics — metoclopramide, domperidone (dopamine antagonism)
- Antidepressants — SSRIs, tricyclics (serotonin effects on prolactin)
- Antihypertensives — verapamil, methyldopa (various mechanisms)
- Opioids — morphine, methadone (inhibit dopamine release)
- Hormonal — estrogens, oral contraceptives (direct stimulation)
- H2 blockers — cimetidine, ranitidine (antiandrogenic effect)
Reproductive and Breast History
- Pregnancy status: Could you be pregnant?
- Lactation: Are you breastfeeding or recently stopped?
- Menstrual history: Regular periods? Any changes?
- Menopausal status: When was your last period?
- Previous breast problems: Biopsies, cysts, surgeries?
- Family history: Breast or ovarian cancer?
- Hormone therapy: HRT or contraceptives?
Other Medical History
- Thyroid disease: Known hypothyroidism?
- Pituitary problems: Previous tumors or surgery?
- Renal disease: Chronic kidney disease affects prolactin clearance
- Liver disease: Affects hormone metabolism
- Autoimmune conditions: Associated with various endocrine disorders
Social and Physical Factors
- Nipple manipulation: Frequent self-examination? Sexual stimulation?
- Chest wall trauma: Recent surgery, shingles, injury?
- Nipple piercing: Can stimulate prolactin release
- Tight clothing: Chronic friction or irritation
- Stress: Can affect prolactin levels
Establishing the Timeline
Critical Timeline Questions
- Onset: “When did you first notice the discharge?” — sudden onset may suggest papilloma or duct ectasia
- Duration: “How long has this been going on?” — chronic discharge more often benign
- Progression: “Has it gotten better, worse, or stayed the same?”
- Cyclical variation: “Does it change with your menstrual cycle?” — suggests hormonal influence
- Temporal associations: “Did anything change around when this started?” — new medication, stress, illness
4. Physical Examination
A systematic approach for evaluating nipple discharge
Systematic Framework: Use the “General → Breast → Nipple → Regional → Systemic” approach for complete examination of patients presenting with nipple discharge. Always examine both breasts for comparison, even when discharge is unilateral.
General Inspection
- Overall appearance: Well or unwell? Signs of systemic illness?
- Body habitus: Obesity (increased peripheral estrogen conversion), cachexia (concerning for malignancy)
- Signs of endocrine disease: Myxedematous facies, goiter, acromegalic features, Cushingoid appearance
- Visual fields (gross assessment): If galactorrhea present, check for bitemporal hemianopia suggesting pituitary mass
- Skin: Pallor, jaundice, signs of liver disease (spider nevi, palmar erythema)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) | Suggests breast abscess or mastitis |
| Heart Rate | Bradycardia or tachycardia | Bradycardia may suggest hypothyroidism |
| Blood Pressure | Hypertension or hypotension | May be relevant in endocrine disorders |
| Weight and BMI | Obesity, recent weight changes | Obesity increases breast cancer risk; weight gain may suggest hypothyroidism |
Breast Examination
Inspection (Patient Seated, Arms at Sides, Then Raised)
- Symmetry: Compare size, shape, and contour of both breasts
- Skin changes: Erythema, peau d’orange (suggesting lymphatic obstruction), dimpling, retraction
- Visible masses: Asymmetric fullness or bulge
- Nipple position: Deviation, inversion, retraction (new versus longstanding)
- Nipple surface: Eczema, scaling, crusting, ulceration (Paget disease)
- Spontaneous discharge: Note if discharge is visible without manipulation
Palpation (Patient Supine, Arm Behind Head)
- Technique: Use flat of fingers in concentric circles or vertical strips; cover all quadrants and tail of Spence
- Breast tissue: Note any masses — location, size, shape, consistency, mobility, tenderness
- Subareolar region: Palpate carefully for dilated ducts or subareolar masses
- Trigger point: Can gentle pressure on a specific area reproduce the discharge? (localizes the affected duct)
Nipple Examination
| Finding | Description | Clinical Significance |
|---|---|---|
| Discharge color | Note exact color: milky, serous (clear/watery), bloody, green, yellow, brown, purulent | Bloody or clear serous most concerning for malignancy |
| Discharge origin | Identify if from single duct orifice (uniductal) or multiple (multiductal) | Uniductal suggests localized pathology (papilloma, carcinoma) |
| Spontaneity | Does discharge appear without manipulation, or only with expression? | Spontaneous discharge more concerning |
| Laterality | Unilateral versus bilateral | Unilateral more concerning; bilateral suggests systemic cause |
| Nipple skin | Eczematous changes, erosion, ulceration, crusting | Paget disease — indicates underlying carcinoma |
| Nipple retraction | New inversion or deviation of nipple | May indicate underlying tumor or duct ectasia |
Technique for Expressing Discharge
To identify the affected duct, apply gentle pressure with one finger at the areolar margin and move circumferentially around the nipple (like the positions on a clock face). When discharge appears, note the clock position — this indicates which duct is involved and guides surgical planning if excision is needed. Document as “discharge expressed from 2 o’clock position of right nipple.”
Regional Lymph Node Examination
Axillary Lymph Nodes
- Technique: Support patient’s arm; palpate high into axilla then down along chest wall
- Central nodes: Against chest wall in mid-axilla
- Pectoral nodes: Along anterior axillary fold
- Subscapular nodes: Along posterior axillary fold
- Lateral nodes: Along upper humerus
- Findings: Note size, number, consistency, fixation, tenderness
Other Lymph Node Groups
- Supraclavicular: Palpate in supraclavicular fossa — if involved, suggests advanced disease
- Infraclavicular: Below clavicle — drainage from upper outer breast
- Cervical: Check if systemic disease suspected
- Significance: Enlarged, hard, fixed nodes raise concern for malignancy
Systemic Examination (When Galactorrhea is Present)
| System | What to Examine | Looking For |
|---|---|---|
| Thyroid | Inspect and palpate thyroid gland | Goiter, nodules (hypothyroidism causes hyperprolactinemia) |
| Eyes | Visual field testing by confrontation | Bitemporal hemianopia (pituitary macroadenoma compressing optic chiasm) |
| Skin | Texture, temperature, hair distribution | Dry skin, hair loss, delayed relaxation of reflexes (hypothyroidism) |
| Abdomen | Hepatomegaly, ascites | Liver disease affects hormone metabolism and prolactin clearance |
| Chest wall | Scars, herpes zoster rash | Chest wall stimulation can cause hyperprolactinemia via neural reflexes |
| Neurological | Cranial nerves, particularly III, IV, VI | Pituitary mass effect (ophthalmoplegia from cavernous sinus involvement) |
Expected Findings by Etiology
| Condition | Discharge Character | Breast Findings | Other Findings |
|---|---|---|---|
| Intraductal papilloma | Bloody or serous; spontaneous; uniductal; unilateral | Often no palpable mass; may have small subareolar nodule; trigger point positive | Normal systemic examination |
| Breast carcinoma | Bloody or serous; spontaneous; unilateral | May have palpable mass (hard, irregular, fixed); skin changes; nipple retraction | Axillary lymphadenopathy if advanced |
| Mammary duct ectasia | Multicolored; thick; bilateral; multiductal | Subareolar mass or thickening; nipple retraction possible; periareolar inflammation | Normal systemic examination |
| Galactorrhea (prolactinoma) | Milky; bilateral; multiductal; expressed | Normal breast tissue | Visual field defect; headache; amenorrhea |
| Galactorrhea (hypothyroidism) | Milky; bilateral; multiductal | Normal breast tissue | Goiter; dry skin; bradycardia; delayed reflexes |
| Fibrocystic changes | Green or yellow; bilateral; multiductal; cyclical | Nodular, lumpy breast tissue; tenderness; multiple cysts | Normal systemic examination |
| Paget disease | Serous or bloody; unilateral | Eczematous nipple changes; underlying mass in 50% | May have axillary lymphadenopathy |
| Breast abscess | Purulent; unilateral; malodorous | Tender, fluctuant mass; erythema; warmth; induration | Fever; tachycardia; leukocytosis |
Important Teaching Point
Normal examination is common! Many causes of nipple discharge, including intraductal papilloma (the most common cause of pathologic discharge), present with completely normal breast examination findings aside from the discharge itself. A normal examination does not exclude significant pathology, including malignancy. The absence of a palpable mass is not reassuring when pathologic discharge characteristics are present. Imaging is essential regardless of physical examination findings.
Documentation Checklist
Complete documentation should include:
- Discharge characteristics: color, consistency, spontaneous versus expressed
- Laterality: unilateral versus bilateral
- Duct involvement: uniductal versus multiductal; clock position if identifiable
- Breast examination findings: masses, skin changes, nipple changes
- Lymph node status: axillary, supraclavicular
- Systemic findings if relevant: thyroid, visual fields
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Step-by-Step Approach to Nipple Discharge:
- Step 1: Determine if discharge is physiologic or pathologic based on characteristics
- Step 2: If physiologic (bilateral, multiductal, milky) — consider galactorrhea workup
- Step 3: If pathologic (spontaneous, unilateral, uniductal, bloody/serous) — pursue breast imaging and possible surgical evaluation
- Step 4: Consider age, menopausal status, and associated findings to refine differential
Pathologic Nipple Discharge (Spontaneous, Unilateral, Uniductal)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 50-60%) | Intraductal papilloma | Bloody or serous discharge; usually no palpable mass; single duct; premenopausal women most common | Multiple papillomas increase cancer risk |
| COMMON (approximately 15-20%) | Mammary duct ectasia | Multicolored (green, brown) thick discharge; may be bilateral; subareolar mass; nipple retraction; perimenopausal | Periareolar inflammation; nipple inversion |
| LESS COMMON (approximately 10-15%) | Breast carcinoma (ductal carcinoma in situ or invasive) | Bloody or clear discharge; may have associated mass; skin changes; new nipple retraction | Palpable mass; skin dimpling; lymphadenopathy; postmenopausal |
| LESS COMMON (approximately 5-10%) | Fibrocystic changes with duct involvement | Green or yellow discharge; cyclical symptoms; nodular breasts; bilateral tenderness | Usually benign; dominant mass needs evaluation |
| UNCOMMON (approximately 2-5%) | Paget disease of the nipple | Serous or bloody discharge; eczematous nipple changes; unilateral; underlying mass in 50% | Always indicates underlying carcinoma |
| UNCOMMON (less than 2%) | Breast abscess or periductal mastitis | Purulent discharge; pain; erythema; fever; may follow lactation or occur with duct ectasia | Rule out inflammatory breast cancer if not responding to antibiotics |
Physiologic Discharge and Galactorrhea (Bilateral, Multiductal, Milky)
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Drug-induced hyperprolactinemia | 20-30% of galactorrhea cases | Temporal relationship with medication initiation; antipsychotics, antiemetics most common; resolves with drug cessation |
| COMMON | Idiopathic galactorrhea | 30-40% of galactorrhea cases | Normal prolactin levels; normal imaging; diagnosis of exclusion; may be due to increased breast sensitivity to prolactin |
| COMMON | Prolactinoma (pituitary adenoma) | 20-25% of galactorrhea cases | Elevated prolactin; amenorrhea; headaches; visual field defects if macroadenoma; prolactin level correlates with tumor size |
| LESS COMMON | Primary hypothyroidism | 5-10% of galactorrhea cases | Elevated TSH; fatigue; weight gain; cold intolerance; resolves with thyroid hormone replacement |
| LESS COMMON | Physiologic (pregnancy, lactation, post-lactation) | Variable | Recent pregnancy or breastfeeding; discharge may persist months after weaning; positive pregnancy test |
| LESS COMMON | Chest wall stimulation | 5% of galactorrhea cases | History of thoracic surgery, trauma, herpes zoster, nipple piercing, chronic nipple manipulation |
| UNCOMMON | Non-functioning pituitary adenoma (stalk effect) | Less than 5% | Mildly elevated prolactin (usually less than 100 ng/mL); mass effect symptoms; other pituitary hormone deficiencies |
| UNCOMMON | Other hypothalamic or pituitary lesions | Less than 5% | Craniopharyngioma, sarcoidosis, histiocytosis, metastases; additional neurological symptoms |
| UNCOMMON | Chronic renal failure | Less than 5% | Known kidney disease; reduced prolactin clearance; elevated creatinine |
Anatomical Approach to Nipple Discharge
Ductal Origin
Intraductal papilloma
Ductal carcinoma in situ
Invasive ductal carcinoma
Mammary duct ectasia
Lobular and Parenchymal Origin
Fibrocystic changes
Breast cyst (if communicates with duct)
Fibroadenoma (rare cause)
Invasive lobular carcinoma (rare)
Nipple Surface (Pseudo-discharge)
Paget disease of the nipple
Nipple eczema or dermatitis
Nipple adenoma
Traumatic erosion
Systemic or Endocrine Origin
Prolactinoma
Hypothyroidism
Drug-induced hyperprolactinemia
Pregnancy and lactation
Drug-Induced Nipple Discharge (Galactorrhea)
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Antipsychotics (typical) Haloperidol, chlorpromazine | Dopamine D2 receptor blockade in tuberoinfundibular pathway | High incidence (up to 50%); dose-dependent; prolactin can be markedly elevated | Days to weeks after cessation |
| Antipsychotics (atypical) Risperidone, paliperidone | Strong D2 blockade (risperidone has highest risk among atypicals) | Risperidone: high risk; olanzapine, quetiapine: lower risk; aripiprazole: minimal risk | 1-2 weeks typically |
| Antiemetics Metoclopramide, domperidone | Peripheral and central dopamine receptor blockade | Common with prolonged use; metoclopramide crosses blood-brain barrier more than domperidone | Days to 1 week |
| Antidepressants SSRIs, tricyclics, MAOIs | Serotonin stimulation of prolactin release; reduced dopamine via serotonin effects | Less common than antipsychotics; usually modest prolactin elevation | 1-2 weeks |
| Opioids Morphine, methadone, codeine | Inhibition of hypothalamic dopamine release via mu receptors | Common with chronic use; dose-dependent | Days after cessation |
| Antihypertensives Verapamil, methyldopa, reserpine | Verapamil: unknown mechanism; Methyldopa: inhibits dopamine synthesis; Reserpine: depletes dopamine | Less common; usually modest effect | 1-2 weeks |
| H2 receptor blockers Cimetidine, ranitidine | Antiandrogenic effect; may block dopamine receptors at high doses | Rare; more common with cimetidine; usually with high doses | Days |
| Estrogens and oral contraceptives | Direct stimulation of lactotroph proliferation and prolactin gene transcription | Usually with high-dose estrogen; less common with modern low-dose pills | Weeks to months |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Bloody discharge, uniductal, no mass | Intraductal papilloma | Mammogram + ultrasound; ductography or MRI; surgical excision |
| Bloody discharge with palpable mass | Breast carcinoma until proven otherwise | Urgent mammogram + ultrasound; core biopsy of mass |
| Milky discharge, bilateral, amenorrhea | Hyperprolactinemia (prolactinoma or drug-induced) | Serum prolactin; TSH; medication review; MRI pituitary if elevated |
| Multicolored sticky discharge, perimenopausal | Mammary duct ectasia | Mammogram to exclude malignancy; usually observation |
| Eczematous nipple with discharge | Paget disease of the nipple | Punch biopsy of nipple skin; mammogram; MRI |
| Purulent discharge with fever and breast erythema | Breast abscess or mastitis | Ultrasound for abscess; antibiotics; drainage if fluctuant |
| Milky discharge, recent antipsychotic started | Drug-induced galactorrhea | Confirm with prolactin level; consider medication switch |
| Milky discharge with fatigue and weight gain | Hypothyroidism | TSH and free T4; thyroid hormone replacement |
| Galactorrhea with headaches and visual changes | Pituitary macroadenoma | Urgent prolactin level; MRI pituitary; visual field testing |
| Clear discharge, postmenopausal, no other findings | Consider carcinoma; papilloma less common at this age | Mammogram + ultrasound; low threshold for MRI and surgical excision |
Differential Diagnosis by Age Group
| Age Group | Most Common Causes | Malignancy Risk | Special Considerations |
|---|---|---|---|
| Under 35 years | Fibrocystic changes; intraductal papilloma; galactorrhea (physiologic or drug-induced) | Low (less than 3%) | Pregnancy must be excluded; consider medication review |
| 35-50 years | Intraductal papilloma; fibrocystic changes; duct ectasia; galactorrhea | Moderate (5-10%) | Full workup for pathologic discharge; prolactinoma possible |
| Over 50 years (postmenopausal) | Duct ectasia; carcinoma; papilloma | Higher (15-20%) | All spontaneous discharge requires imaging; low threshold for surgical excision |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Investigation Strategy: The approach differs based on discharge type:
- Pathologic discharge (spontaneous, unilateral, uniductal, bloody/serous): Focus on breast imaging to exclude malignancy
- Physiologic discharge (bilateral, multiductal, milky): Focus on endocrine workup for hyperprolactinemia
Baseline Investigations for Pathologic Discharge
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Mammography | First-line imaging for women over 30-40 years | Mass, microcalcifications, architectural distortion, dilated retroareolar duct | May be normal in 50-70% of pathologic discharge cases; does not exclude pathology |
| Breast ultrasound | Complement to mammography; first-line for women under 30 | Intraductal mass, dilated duct, cyst, solid mass | Better for dense breasts; can identify papillomas as intraductal masses; guides biopsy |
| Discharge cytology | Analysis of discharge fluid for malignant cells | Atypical or malignant cells; papillary cells; inflammatory cells | Low sensitivity (less than 50%); negative result does not exclude malignancy; largely abandoned in many centers |
| Pregnancy test | Exclude pregnancy in reproductive-age women | Positive hCG | Essential before any radiological investigation; explains physiologic galactorrhea |
Advanced Imaging for Pathologic Discharge
| Investigation | When to Order | Advantages | Limitations |
|---|---|---|---|
| Breast MRI | Negative mammogram and ultrasound with persistent pathologic discharge; preoperative planning | Highest sensitivity for detecting intraductal lesions (greater than 90%); can identify occult malignancy | Lower specificity; expensive; requires IV contrast; may lead to additional biopsies |
| Ductography (galactography) | Localize intraductal lesion prior to surgery; identify single duct for excision | Directly visualizes ductal system; shows filling defects (papilloma, carcinoma) | Technically challenging; requires active discharge; largely replaced by MRI in many centers |
| Ductoscopy | Direct visualization of ductal epithelium; available in specialized centers | Can visualize and biopsy intraductal lesions directly | Limited availability; technically demanding; not widely used |
The Role of MRI in Nipple Discharge Workup
When mammography and ultrasound are negative but pathologic discharge persists, MRI has become the investigation of choice. Studies show MRI detects intraductal lesions in 80-90% of cases where conventional imaging is negative. MRI can identify the causative lesion and guide surgical planning. However, a negative MRI does not completely exclude pathology, and some centers still recommend surgical duct excision for persistent bloody discharge even with negative imaging.
Targeted Investigations for Galactorrhea (Milky Discharge)
Step 1: Initial Laboratory Tests
| Test | Purpose | Expected Findings | Interpretation |
|---|---|---|---|
| Serum prolactin | Confirm hyperprolactinemia | Normal: less than 25 ng/mL in women; less than 20 ng/mL in men | 25-100 ng/mL: drugs, stalk effect, microprolactinoma; greater than 200 ng/mL: macroprolactinoma |
| TSH (thyroid-stimulating hormone) | Exclude hypothyroidism | Normal: 0.4-4.0 mIU/L | Elevated TSH indicates hypothyroidism causing secondary hyperprolactinemia |
| Pregnancy test (beta-hCG) | Exclude pregnancy | Negative in non-pregnant | Pregnancy is a physiologic cause of galactorrhea |
| Renal function (creatinine, eGFR) | Assess renal function | Normal creatinine and eGFR | Chronic kidney disease reduces prolactin clearance |
| Liver function tests | Assess hepatic function | Normal ALT, AST, bilirubin | Liver disease affects hormone metabolism |
Step 2: Pituitary Imaging (If Prolactin Elevated)
MRI Pituitary with Gadolinium
- Indication: Prolactin greater than 100 ng/mL, or persistent elevation after excluding drugs and hypothyroidism
- Technique: Dedicated pituitary protocol with thin cuts through sella
- Findings: Microadenoma (less than 10 mm), macroadenoma (greater than or equal to 10 mm), stalk deviation, empty sella
Interpreting Prolactin Levels
- 25-50 ng/mL: Drugs, stress, chest wall stimulation, idiopathic
- 50-100 ng/mL: Microprolactinoma, stalk effect, hypothyroidism
- 100-200 ng/mL: Microprolactinoma or small macroprolactinoma
- Greater than 200 ng/mL: Macroprolactinoma (prolactin correlates with tumor size)
- Greater than 1000 ng/mL: Giant prolactinoma
Step 3: Additional Testing for Macroadenoma
| Test | Indication | Purpose |
|---|---|---|
| Visual field testing (formal perimetry) | Macroadenoma on MRI; visual symptoms | Detect optic chiasm compression (bitemporal hemianopia) |
| Pituitary hormone panel | Macroadenoma; suspected panhypopituitarism | Assess for deficiency of other pituitary hormones (ACTH, TSH, FSH, LH, GH) |
| IGF-1 (insulin-like growth factor) | Clinical features of acromegaly | Screen for growth hormone excess if co-secreting adenoma suspected |
Tissue Diagnosis for Breast Lesions
| Procedure | Indication | Technique | Notes |
|---|---|---|---|
| Core needle biopsy (ultrasound-guided) | Visible lesion on imaging | 14-gauge needle; multiple cores obtained | Preferred for solid masses; provides histology |
| Stereotactic biopsy | Microcalcifications seen on mammogram only | Mammographic guidance; vacuum-assisted biopsy | For lesions not visible on ultrasound |
| MRI-guided biopsy | Lesion visible only on MRI | MRI-compatible biopsy system | Specialized equipment required; for MRI-only visible lesions |
| Surgical duct excision (microdochectomy) | Pathologic discharge with negative imaging; single duct identified | Excision of single duct from nipple to periphery | Both diagnostic and therapeutic; preserves breastfeeding potential |
| Central duct excision (Hadfield procedure) | Pathologic discharge involving multiple ducts; duct ectasia with symptoms | Excision of all major retroareolar ducts | Eliminates breastfeeding capacity; definitive for recurrent discharge |
| Nipple skin biopsy (punch biopsy) | Suspected Paget disease (eczematous nipple changes) | 4-6 mm punch biopsy of affected nipple skin | Confirms Paget cells; underlying carcinoma workup required |
Summary: Investigation Pathway
Pathologic Discharge Pathway
- Mammography and ultrasound (first-line for all patients with pathologic discharge)
- If lesion identified: Core needle biopsy for tissue diagnosis
- If imaging negative but discharge persists: Breast MRI
- If MRI shows lesion: MRI-guided or second-look ultrasound biopsy
- If all imaging negative: Consider surgical duct excision (especially for bloody discharge)
Galactorrhea Pathway
- Pregnancy test (exclude pregnancy first)
- Medication review (identify causative drugs)
- Serum prolactin and TSH (baseline endocrine tests)
- If prolactin elevated and no drug cause: MRI pituitary with gadolinium
- If macroadenoma: Visual field testing; pituitary hormone panel
- If prolactin normal: Diagnosis is idiopathic galactorrhea
Special Investigation Considerations
| Scenario | Recommended Approach | Rationale |
|---|---|---|
| Young woman (under 30) with pathologic discharge | Ultrasound first; mammography if indicated by ultrasound findings | Dense breast tissue limits mammography sensitivity; reduce radiation exposure |
| Postmenopausal woman with any spontaneous discharge | Full imaging workup regardless of discharge color | Higher malignancy risk; any spontaneous discharge is concerning |
| High-risk patient (BRCA mutation, strong family history) | Low threshold for MRI; consider genetic counseling | Increased baseline malignancy risk warrants more aggressive workup |
| Recurrent discharge after duct excision | Repeat imaging; consider central duct excision if not previously done | May indicate residual or new pathology; papillomatosis possible |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Bloody discharge with palpable breast mass | EMERGENT | Urgent breast imaging within 1-2 weeks; expedited referral to breast surgery |
| Eczematous nipple changes with discharge (suspected Paget disease) | EMERGENT | Punch biopsy of nipple skin; breast imaging; surgical oncology referral |
| Galactorrhea with severe headache and visual disturbance | EMERGENT | Urgent prolactin level; emergent MRI pituitary; neurosurgery consultation |
| Purulent discharge with fever, breast erythema, and fluctuance | URGENT | Ultrasound to assess for abscess; antibiotics; drainage if collection present |
| Spontaneous bloody or clear discharge, no mass | URGENT | Breast imaging within 2-4 weeks; surgical referral if imaging abnormal or negative with persistent discharge |
| Postmenopausal woman with any spontaneous discharge | URGENT | Full breast imaging workup; higher threshold of suspicion for malignancy |
| Milky bilateral discharge with amenorrhea | ROUTINE | Pregnancy test; prolactin and TSH; medication review; MRI if prolactin elevated |
| Green or yellow multiductal discharge, bilateral | ROUTINE | Clinical assessment; mammogram if over 40 or other risk factors; often reassurance sufficient |
| Expressed discharge only, no spontaneous component | ROUTINE | Advise to stop manipulating nipple; reassess in 4-6 weeks; imaging if persists or becomes spontaneous |
Step 2: Classify the Discharge Type
Pathologic Discharge
Criteria: Spontaneous AND unilateral AND uniductal AND/OR bloody or clear
Proceed to Breast Imaging Algorithm
Galactorrhea
Criteria: Milky, bilateral, multiductal (may be expressed or spontaneous)
Proceed to Endocrine Workup Algorithm
Physiologic or Benign
Criteria: Expressed only, bilateral, multiductal, non-bloody
Reassurance; stop nipple manipulation; follow-up if changes
Step 3A: Algorithm for Pathologic Discharge
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Bloody uniductal discharge, imaging shows intraductal lesion | Intraductal papilloma (most likely) or carcinoma | Core biopsy if accessible; surgical duct excision for definitive diagnosis and treatment |
| Bloody uniductal discharge, imaging negative | Papilloma (often too small for imaging) | Breast MRI; if still negative, surgical duct excision recommended |
| Clear serous discharge, no mass, imaging negative | Papilloma, early carcinoma, or duct ectasia | MRI; consider surgical excision especially if postmenopausal or persistent |
| Discharge with palpable mass on examination | Carcinoma until proven otherwise | Urgent imaging; core biopsy of mass; do not delay for discharge workup |
| Discharge with microcalcifications on mammogram | Ductal carcinoma in situ or invasive carcinoma | Stereotactic biopsy of calcifications |
| Multicolored sticky discharge, bilateral, perimenopausal | Mammary duct ectasia | Mammogram to exclude malignancy; reassurance; surgery only for severe symptoms |
| Eczematous nipple with serous or bloody discharge | Paget disease of the nipple | Punch biopsy of nipple skin; full breast imaging; MRI to identify underlying carcinoma |
Step 3B: Algorithm for Galactorrhea
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Positive pregnancy test | Physiologic galactorrhea of pregnancy | Normal finding; no further workup for discharge needed |
| Currently breastfeeding or stopped within 6 months | Physiologic post-lactation galactorrhea | Reassurance; may persist for months; check prolactin if persists beyond 6 months |
| Recent initiation of dopamine-blocking medication | Drug-induced hyperprolactinemia | Confirm with prolactin level; discuss with prescriber about alternatives if symptomatic |
| Elevated prolactin (25-100 ng/mL), no obvious cause | Microprolactinoma or idiopathic | MRI pituitary; if negative, diagnosis is idiopathic; treat if symptomatic |
| Elevated prolactin (greater than 200 ng/mL) | Macroprolactinoma | MRI pituitary; visual field testing; endocrinology referral; dopamine agonist therapy |
| Elevated TSH with elevated prolactin | Primary hypothyroidism | Thyroid hormone replacement; galactorrhea resolves with treatment |
| Large pituitary mass with mildly elevated prolactin (less than 100 ng/mL) | Non-functioning adenoma with stalk effect | Full pituitary hormone panel; visual fields; neurosurgery consultation |
| Normal prolactin, normal TSH, not pregnant, no medications | Idiopathic galactorrhea | Reassurance; may offer dopamine agonist if bothersome; breast imaging if any concern |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient asks if bloody discharge means cancer | Explain that most bloody discharge is benign (papilloma) but requires investigation to be certain | Arrange prompt imaging; avoid both dismissing concern and causing undue alarm |
| Mammogram and ultrasound are both negative | Reassess discharge characteristics; if truly pathologic, proceed to MRI | Consider surgical duct excision if MRI also negative but discharge persists |
| Patient refuses surgery for persistent bloody discharge | Document discussion of risks including missing malignancy; offer close surveillance | Repeat imaging at 6 months; re-counsel if discharge persists or changes |
| Prolactin is elevated but patient needs to stay on antipsychotic | Discuss with psychiatrist about switching to prolactin-sparing agent (aripiprazole) | If unable to switch, MRI pituitary to exclude adenoma; monitor symptoms |
| Core biopsy shows papilloma without atypia | Discuss with multidisciplinary team; excision often still recommended | Surgical excision ensures no adjacent carcinoma missed by sampling; resolves discharge |
| Patient has bilateral bloody discharge | This is unusual; still requires full workup of both breasts | Bilateral mammogram and ultrasound; consider bilateral papillomatosis or systemic cause |
| Discharge resolved before imaging appointment | Still proceed with imaging as originally planned | Document that discharge has resolved; imaging can still detect underlying pathology |
| Duct excision pathology shows atypical ductal hyperplasia | Discuss increased future breast cancer risk with patient | Enhanced surveillance; consider risk-reducing strategies; genetics referral if appropriate |
Troubleshooting Persistent or Recurrent Discharge
Ask These Questions
- Was the correct duct excised? — Trigger point technique should identify the involved duct
- Is there more than one papilloma? — Papillomatosis involves multiple ducts; may need more extensive excision
- Was the excision complete? — Residual papilloma can cause recurrence
- Is there an underlying carcinoma that was missed? — Review pathology; consider re-imaging
- Is the patient manipulating the nipple? — Advise cessation of self-examination that expresses discharge
- Has the discharge character changed? — New bloody discharge after excision needs fresh workup
- Is this actually a new discharge from a different duct? — Compare laterality and location
When to Refer
Refer to Breast Surgery
- All pathologic discharge (spontaneous, unilateral, uniductal, bloody or clear)
- Any imaging abnormality requiring biopsy
- Palpable mass associated with discharge
- Negative imaging but persistent pathologic discharge (for duct excision)
- Biopsy showing papilloma, atypia, or malignancy
- Suspected Paget disease
Refer to Endocrinology
- Hyperprolactinemia with pituitary adenoma on MRI
- Macroadenoma requiring medical or surgical management
- Hyperprolactinemia not explained by medications or hypothyroidism
- Associated pituitary hormone deficiencies
- Galactorrhea not responding to treatment
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The “Pathologic Triad” guides urgency: Spontaneous, unilateral and uniductal, and bloody or clear discharge together indicate the highest risk for malignancy (10-15%) and always warrant imaging.
Intraductal papilloma is the most common cause of pathologic bloody discharge: Accounting for 50-60% of cases, papillomas are benign but require excision to exclude adjacent carcinoma and resolve symptoms.
Normal imaging does not exclude significant pathology: Mammography and ultrasound miss up to 50-70% of intraductal lesions. MRI and surgical excision may be needed even with negative conventional imaging.
Prolactin level correlates with tumor size: Levels greater than 200 ng/mL strongly suggest macroprolactinoma. Mildly elevated prolactin (less than 100 ng/mL) with a large pituitary mass indicates stalk effect from a non-functioning adenoma.
Always check TSH before MRI in galactorrhea: Primary hypothyroidism is a reversible cause of hyperprolactinemia. Treating hypothyroidism resolves the galactorrhea without need for pituitary imaging.
Medication review is essential: Drug-induced galactorrhea is one of the most common causes of hyperprolactinemia. Antipsychotics (especially risperidone) and antiemetics (metoclopramide) are frequent culprits.
Paget disease always indicates underlying carcinoma: Eczematous changes of the nipple that do not respond to topical steroids should prompt biopsy. Nearly 100% of Paget disease cases have an associated ductal carcinoma in situ or invasive carcinoma.
Use the “trigger point” technique: Pressing sequentially around the areola to identify which duct produces discharge helps localize the pathology and guides surgical planning for duct excision.
Critical Pitfalls to Avoid
Dismissing bloody discharge because imaging is negative: Negative mammogram and ultrasound do not exclude papilloma or carcinoma. Proceed to MRI and consider surgical excision for persistent pathologic discharge.
Assuming bilateral discharge is always benign: While bilateral discharge is usually physiologic, bilateral bloody discharge still requires investigation of both breasts. Do not let bilaterality create false reassurance.
Treating “nipple eczema” without biopsy: Unilateral, persistent, treatment-resistant nipple eczema is Paget disease until proven otherwise. Failure to biopsy delays diagnosis of underlying carcinoma.
Ordering MRI pituitary before checking TSH: Always exclude hypothyroidism first. Treating hypothyroidism normalizes prolactin without need for pituitary imaging, avoiding unnecessary cost and patient anxiety.
Relying on discharge cytology to exclude malignancy: Cytology has very low sensitivity (less than 50%). A negative cytology result provides no reassurance and should not defer appropriate imaging or surgical workup.
Forgetting to ask about nipple manipulation: Frequent self-examination or repeated expression of discharge can perpetuate the problem. Advising cessation of manipulation may resolve physiologic discharge.
Missing the “stalk effect” diagnosis: A large pituitary mass with only mildly elevated prolactin (less than 100 ng/mL) is likely a non-functioning adenoma compressing the stalk, not a prolactinoma. Management differs significantly.
Being falsely reassured by patient age: While malignancy risk is higher in postmenopausal women, breast cancer can occur at any age. Young women with pathologic discharge still require appropriate workup.
Key Takeaways
- Nipple discharge is classified as physiologic or pathologic based on spontaneity, laterality, duct involvement, and color — this classification drives the entire diagnostic approach.
- The “Pathologic Triad” (spontaneous + unilateral/uniductal + bloody or clear) carries a 10-15% malignancy risk and always requires breast imaging.
- Intraductal papilloma is the most common cause of pathologic bloody discharge (50-60%), followed by duct ectasia and carcinoma.
- Milky bilateral multiductal discharge (galactorrhea) requires endocrine workup: pregnancy test, medication review, prolactin, and TSH before pituitary imaging.
- Normal mammogram and ultrasound do not exclude significant pathology — MRI detects 80-90% of lesions missed by conventional imaging.
- Prolactin level guides diagnosis: greater than 200 ng/mL suggests macroprolactinoma; less than 100 ng/mL with large mass suggests stalk effect.
- Surgical duct excision is both diagnostic and therapeutic for persistent pathologic discharge with negative imaging.
- Paget disease of the nipple (eczematous changes) indicates underlying carcinoma in nearly all cases — always biopsy persistent unilateral nipple skin changes.
- Drug-induced galactorrhea is common — antipsychotics, antiemetics, and opioids are frequent causes that resolve with medication adjustment.
- Postmenopausal women with any spontaneous discharge require thorough investigation due to higher baseline malignancy risk.
Quick Reference Algorithm
Systematic Approach to Nipple Discharge:
- Characterize the discharge: Spontaneous or expressed? Unilateral or bilateral? Uniductal or multiductal? Color?
- Classify as pathologic or physiologic: Pathologic = spontaneous, unilateral, uniductal, bloody or clear
- For pathologic discharge: Mammogram + ultrasound → MRI if negative → Surgical excision if still negative but discharge persists
- For galactorrhea: Pregnancy test → Medication review → Prolactin and TSH → MRI pituitary if prolactin elevated
- Do not forget: Examine the nipple skin for Paget disease; check visual fields if macroadenoma suspected; advise cessation of nipple manipulation for physiologic discharge